JP2022514858A5 - - Google Patents
Info
- Publication number
- JP2022514858A5 JP2022514858A5 JP2021535273A JP2021535273A JP2022514858A5 JP 2022514858 A5 JP2022514858 A5 JP 2022514858A5 JP 2021535273 A JP2021535273 A JP 2021535273A JP 2021535273 A JP2021535273 A JP 2021535273A JP 2022514858 A5 JP2022514858 A5 JP 2022514858A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous solution
- composition according
- solution composition
- acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1821149.0A GB201821149D0 (en) | 2018-12-21 | 2018-12-21 | Novel composition |
| GB1821149.0 | 2018-12-21 | ||
| GB1911581.5 | 2019-08-13 | ||
| GBGB1911581.5A GB201911581D0 (en) | 2019-08-13 | 2019-08-13 | Novel composition |
| PCT/GB2019/053655 WO2020128507A1 (en) | 2018-12-21 | 2019-12-20 | Novel composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514858A JP2022514858A (ja) | 2022-02-16 |
| JP2022514858A5 true JP2022514858A5 (https=) | 2022-12-21 |
| JP7421556B2 JP7421556B2 (ja) | 2024-01-24 |
Family
ID=69104798
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535273A Active JP7421556B2 (ja) | 2018-12-21 | 2019-12-20 | 新規組成物 |
| JP2021535272A Pending JP2022514597A (ja) | 2018-12-21 | 2019-12-20 | 新規組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535272A Pending JP2022514597A (ja) | 2018-12-21 | 2019-12-20 | 新規組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12239685B2 (https=) |
| EP (2) | EP3897573A1 (https=) |
| JP (2) | JP7421556B2 (https=) |
| KR (1) | KR20210114000A (https=) |
| CN (2) | CN113301885A (https=) |
| AU (1) | AU2019411551A1 (https=) |
| BR (1) | BR112021011753A2 (https=) |
| CA (1) | CA3124529A1 (https=) |
| WO (2) | WO2020128507A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12239685B2 (en) | 2018-12-21 | 2025-03-04 | Arecor Limited | Composition |
| WO2020229369A1 (en) * | 2019-05-10 | 2020-11-19 | Xellia Pharmaceuticals Aps | Daptomycin aqueous formulations |
| EP4117625A1 (en) | 2020-03-12 | 2023-01-18 | Baxter International Inc. | Daptomycin formulations containing a combination of sorbitol and mannitol |
| CN116726145A (zh) * | 2022-03-04 | 2023-09-12 | 海南普利制药股份有限公司 | 一种稳定的酯肽类药物组合物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696412B1 (en) * | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
| US6716962B2 (en) | 2000-07-17 | 2004-04-06 | Micrologix Biotech Inc. | Extractive purification of lipopeptide antibiotics |
| WO2002059145A1 (en) | 2000-12-18 | 2002-08-01 | Cubist Pharmaceuticals, Inc. | Methods for preparing purified lipopeptides |
| IL156394A0 (en) | 2000-12-18 | 2004-01-04 | Cubist Pharm Inc | Methods for preparing purified lipopeptides |
| US20060014674A1 (en) * | 2000-12-18 | 2006-01-19 | Dennis Keith | Methods for preparing purified lipopeptides |
| CN100421726C (zh) | 2006-03-06 | 2008-10-01 | 南京凯瑞尔纳米生物技术有限公司 | 包含有肽类药物的纳米复合物滴眼液及其制备方法 |
| WO2011035108A1 (en) | 2009-09-17 | 2011-03-24 | Eagle Pharmaceuticals, Inc. | Formulations of daptomycin |
| WO2011062676A1 (en) | 2009-11-23 | 2011-05-26 | Eagle Pharmaceuticals, Inc. | Formulations of daptomycin |
| US20170348382A1 (en) * | 2014-12-16 | 2017-12-07 | Dr. Reddy's Laboratories Limited | Lyophilized injectable compositions of daptomycin |
| WO2018073269A1 (en) * | 2016-10-21 | 2018-04-26 | Xellia Pharmaceuticals Aps | Liquid formulations of daptomycin |
| RU2770366C2 (ru) * | 2017-08-31 | 2022-04-15 | Кселлия Фармасьютикалз Апс | Препараты даптомицина |
| US12239685B2 (en) | 2018-12-21 | 2025-03-04 | Arecor Limited | Composition |
| WO2020229369A1 (en) | 2019-05-10 | 2020-11-19 | Xellia Pharmaceuticals Aps | Daptomycin aqueous formulations |
-
2019
- 2019-12-20 US US17/416,677 patent/US12239685B2/en active Active
- 2019-12-20 AU AU2019411551A patent/AU2019411551A1/en not_active Abandoned
- 2019-12-20 WO PCT/GB2019/053655 patent/WO2020128507A1/en not_active Ceased
- 2019-12-20 CN CN201980085068.5A patent/CN113301885A/zh active Pending
- 2019-12-20 CN CN201980085263.8A patent/CN113271922A/zh active Pending
- 2019-12-20 CA CA3124529A patent/CA3124529A1/en active Pending
- 2019-12-20 WO PCT/GB2019/053654 patent/WO2020128506A1/en not_active Ceased
- 2019-12-20 EP EP19831844.6A patent/EP3897573A1/en active Pending
- 2019-12-20 BR BR112021011753-9A patent/BR112021011753A2/pt not_active IP Right Cessation
- 2019-12-20 JP JP2021535273A patent/JP7421556B2/ja active Active
- 2019-12-20 EP EP19831843.8A patent/EP3897572A1/en not_active Withdrawn
- 2019-12-20 JP JP2021535272A patent/JP2022514597A/ja active Pending
- 2019-12-20 US US17/416,661 patent/US20220072090A1/en not_active Abandoned
- 2019-12-20 KR KR1020217023234A patent/KR20210114000A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022514858A5 (https=) | ||
| JP2014518276A5 (https=) | ||
| JP2015525762A5 (https=) | ||
| US5719119A (en) | Parenteral nutrition therapy with amino acids | |
| RU2013117209A (ru) | Буферные глазные композиции и способы их применения | |
| CA2672902A1 (en) | Formulations | |
| JP2022514597A5 (https=) | ||
| JP2010521994A5 (https=) | ||
| JP2004532217A5 (https=) | ||
| RU2012144771A (ru) | Стабильные водные композиции белка mia/cd-rap | |
| RU2006122638A (ru) | Фармацевтический препарат, включающий антитело против рецептора egf | |
| JP2011507530A5 (https=) | ||
| RU2002103315A (ru) | Офтальмическая композиция, содержащая кетотифен | |
| JP2013519720A5 (https=) | ||
| NO20080697L (no) | Modifiserte farmasoytiske doseringsformer for frigivelse av syklooksygenase enzyminhibitor | |
| EP0250559A1 (en) | Parenteral nutrition therapy with amino acids | |
| JP2015110646A5 (https=) | ||
| JP2019533679A5 (https=) | ||
| GB2429205A (en) | Salts of dihydrojasmonic acid and use thereof in agriculture | |
| RU2004119056A (ru) | Составленные на основе воды фармацевтические композиции водорастворимых пролекарств пропофола | |
| WO2006103274A8 (fr) | Inhibiteurs d'age | |
| RU2019137020A (ru) | Составы со сниженным окислением | |
| Pope | The neutralization of isoniazid activity in Mycobacterium tuberculosis by certain metabolites | |
| BE1022290B1 (fr) | Procede de fermentation | |
| RU2014115289A (ru) | Композиция пазопаниба |